The sequence of chemotherapy and anti-PD-1 antibody influence the efficacy of neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell cancer: A phase II study.
Lingdi Zhao(Zhengzhou University), Quanli Gao(Zhengzhou University), Baozhen Ma(Henan Cancer Hospital), Xiaomin Fu(Zhengzhou University), Hongwei Lin(Zhengzhou University), Yonghao Yang(Army Medical University), Yong Zhang, Wenqun Xing(Zhengzhou University), Yiman Shang(Henan Cancer Hospital), Guanghui Liang(Zhengzhou University), Zibing Wang(Huazhong University of Science and Technology)
Cited by 15
Related Papers
Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome
|Science Immunology|2020|555
IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor
|Nature Immunology|2021|374
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
|JAMA|2024|359